Menopausal hormone therapy under difficult circumstances

Bronwyn Stuckey

Keogh Institute for Medical Research; Department of Endocrinology, Sir Charles Gairdner Hospital; School of Medicine and Pharmacology, University of Western Australia, Nedlands, WA, Australia 

Oestrogen-containing menopausal hormone therapy (MHT) is the gold standard for the treatment of vasomotor symptoms of the menopause. Although one may have a favourite formulation of oestrogen or of oestrogen and progestogen, there are times when that formulation does not suit a particular woman. This may be either because of stage of menopause, or medical history, or co-morbidities, or side-effects, or simply patient preference. One size does not always fit all. This presentation will present real-life case histories where a modification of MHT delivery, dose, or formulation was required, and will discuss the evidence base for efficacy and safety in each case.


Biography:

Professor Bronwyn Stuckey is an endocrinologist with a clinical and research interest in reproductive endocrinology. She is Consultant Endocrinologist in the Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, Western Australia and Clinical Professor in the School of Medicine and Pharmacology, University of Western Australia.

She is also the Medical Director of the Keogh Institute for Medical Research which conducts both clinics and research for both men and women. The focus of her research and that of the Institute is on the interface between reproduction and reproductive hormones and metabolism.